Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TEBENTAFUSP-TEBN for Choroid melanoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where TEBENTAFUSP-TEBN was used for Choroid melanoma.

Most Reported Side Effects for TEBENTAFUSP-TEBN

Side Effect Reports % Deaths Hosp.
Pyrexia 63 18.0% 7 32
Cytokine release syndrome 59 16.9% 11 26
Hypotension 47 13.4% 7 33
Rash 43 12.3% 2 21
Disease progression 42 12.0% 9 6
Chills 38 10.9% 4 21
Product dose omission issue 37 10.6% 0 11
Malignant neoplasm progression 32 9.1% 3 4
Nausea 29 8.3% 2 12
Vomiting 22 6.3% 1 13
Pruritus 21 6.0% 0 14
Death 17 4.9% 17 4
Fatigue 15 4.3% 1 6
Asthenia 12 3.4% 4 9
Hypoxia 12 3.4% 3 7

Other Indications for TEBENTAFUSP-TEBN

Product used for unknown indication (127) Metastatic ocular melanoma (114) Uveal melanoma (72) Metastatic malignant melanoma (7)

Other Drugs Used for Choroid melanoma

IPILIMUMAB (46) NIVOLUMAB (42) PEMBROLIZUMAB (20) RANIBIZUMAB (14) TEBENTAFUSP (8) BEVACIZUMAB (7) FOTEMUSTINE (5) SORAFENIB (5)

Related Pages

TEBENTAFUSP-TEBN Full Profile All Choroid melanoma Drugs TEBENTAFUSP-TEBN Demographics TEBENTAFUSP-TEBN Timeline